Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome
SGLT2i was associated with a lower risk of AF recurrence after catheter ablation independently of MetS status or BMI spectrum.
Authors
- Changsheng Ma (ORCID: https://orcid.org/0000-0002-5387-5957)
- Qi Guo (ORCID: https://orcid.org/0000-0002-4461-2995)
- Chao Jiang (ORCID: https://orcid.org/0000-0003-1138-7960)
- Hang Guo (ORCID: https://orcid.org/0009-0008-3937-1921)
- Zixu Zhao (ORCID: https://orcid.org/0000-0002-1311-4299)
- Liu He (ORCID: https://orcid.org/0000-0002-1349-5343)
- Deyong Long (ORCID: https://orcid.org/0000-0003-4604-5346)
- Caihua Sang
- Jianzeng Dong (ORCID: https://orcid.org/0000-0001-7299-7805)
- Hui Xu (ORCID: https://orcid.org/0000-0001-8189-2917)
- Wenyu Shao (ORCID: https://orcid.org/0000-0001-8853-1735)
- Zejun Yang (ORCID: https://orcid.org/0009-0004-2567-3444)
- Xiao Wang (ORCID: https://orcid.org/0000-0002-8420-8911)
- Xin Du (ORCID: https://orcid.org/0000-0003-2179-6717)
- Xu Yang (ORCID: https://orcid.org/0000-0002-3615-3063)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Anzhen Hospital (CN)
- China National Health Development Research Center (CN)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1111/jce.70073
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78